HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Birth Weight in Different Etiologies of Disorders of Sex Development.

AbstractCONTEXT:
It is well established that boys are heavier than girls at birth. Although the cause of birth weight (BW) difference is unknown, it has been proposed that it could be generated from prenatal androgen action.
OBJECTIVE:
The aim of the current study was to determine the BW of children with disorders of sex development (DSD) of different etiologies and to evaluate the effects of androgen action on BW.
METHODS:
Data regarding diagnosis, BW, gestational age, karyotype, and concomitant conditions were collected from the International Disorders of Sex Development (I-DSD) Registry (www.i-dsd). BW standard deviation score was calculated according to gestational age. Cases were evaluated according to disorder classification in I-DSD (i.e., disorders of gonadal development, androgen excess, androgen synthesis, androgen action, nonspecific disorder of undermasculinization groups, and Leydig cell defect).
RESULTS:
A total of 533 cases were available; 400 (75%) cases were 46,XY, and 133 (25%) cases were 46,XX. Eighty cases (15%) were born small for gestational age (SGA). Frequency of SGA was higher in the 46,XY group (17.8%) than in the 46,XX (6.7%) group (P = 0.001). Mean BW standard deviation scores of cases with androgen excess and androgen deficiency [in disorders of gonadal development, androgen synthesis, and Leydig cell defect groups and androgen receptor gene (AR) mutation-positive cases in disorders of androgen action groups] were similar to normal children with the same karyotype. SGA birth frequency was higher in the AR mutation-negative cases in disorders of androgen action group and in the nonspecific disorders of the undermasculinization group.
CONCLUSIONS:
BW dimorphism is unlikely to be explained by fetal androgen action per se. 46,XY DSDs due to nonspecific disorders of undermasculinization are more frequently associated with fetal growth restriction, SGA, and concomitant conditions.
AuthorsSukran Poyrazoglu, Feyza Darendeliler, S Faisal Ahmed, Ieuan Hughes, Jillian Bryce, Jipu Jiang, Martina Rodie, Olaf Hiort, Sabine E Hannema, Silvano Bertelloni, Lidka Lisa, Tulay Guran, Martine Cools, An Desloovere, Hedi L Claahsen-van der Grinten, Anna Nordenstrom, Paul-Martin Holterhus, Birgit Kohler, Marek Niedziela, Nils Krone
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 102 Issue 3 Pg. 1044-1050 (Mar 01 2017) ISSN: 1945-7197 [Electronic] United States
PMID28359094 (Publication Type: Journal Article)
CopyrightCopyright © 2017 by the Endocrine Society
Chemical References
  • Androgens
Topics
  • Androgen-Insensitivity Syndrome (metabolism)
  • Androgens (metabolism)
  • Birth Weight (physiology)
  • Disorder of Sex Development, 46,XY (metabolism)
  • Disorders of Sex Development (metabolism)
  • Europe
  • Female
  • Fetal Growth Retardation (metabolism)
  • Gestational Age
  • Humans
  • Hyperandrogenism (metabolism)
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Male
  • Registries
  • Sex Characteristics
  • Testis (abnormalities, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: